34
RETINOPATHY

Module 205.2 en

Embed Size (px)

Citation preview

Page 1: Module 205.2 en

RETINOPATHY

Page 2: Module 205.2 en

Objectives

Page 3: Module 205.2 en

Eye disease in people with diabetes

Page 4: Module 205.2 en

Transient changes in vision

Page 5: Module 205.2 en

Retinopathy in people with diabetes

Page 6: Module 205.2 en

When to screen for retinopathy

Page 7: Module 205.2 en

Prevalence (%) ranges for retinopathy

Page 8: Module 205.2 en

Risk factors

Page 9: Module 205.2 en

Intensive therapy - type 1 diabetes

Page 10: Module 205.2 en

Intensive therapy - type 2 diabetes

Page 11: Module 205.2 en

Screening tests

Page 12: Module 205.2 en

Diabetic retinopathy

Page 13: Module 205.2 en

Normal retina

Page 14: Module 205.2 en

Mild-moderate non-proliferative diabetic retinopathy (NPDR)

Page 15: Module 205.2 en

Severe non-proliferative retinopathy

Page 16: Module 205.2 en

Classifications

Page 17: Module 205.2 en

Proliferative retinopathy

Page 18: Module 205.2 en

Advanced proliferative retinopathy

Page 19: Module 205.2 en

Vitreous haemorrhage

Page 20: Module 205.2 en

Macular oedema

Page 21: Module 205.2 en

Investigations

Page 22: Module 205.2 en

Fluorescein angiogram

Page 23: Module 205.2 en

Fluorescein leakage

Page 24: Module 205.2 en

Treatment

Page 25: Module 205.2 en

Pan-photocoagulation for proliferative retinopathy

Page 26: Module 205.2 en

Pan-retinal laser photocoagulation

Page 27: Module 205.2 en

Grid laser for macular oedema

Page 28: Module 205.2 en

Laser therapy

Page 29: Module 205.2 en

Recommendations

Page 30: Module 205.2 en

Use of medical therapies

Page 31: Module 205.2 en

Special populations: Pregnancy

Page 32: Module 205.2 en

Special populations: The older person

Page 33: Module 205.2 en

Summary

Page 34: Module 205.2 en

References